Caixin App
Newsletter
Go
Sections
Sections
Finance
Business
Tech
Economy
China
World
Editorial & Opinion
Weekend Long Read
Research & Analysis
Lifestyle
Books & Arts
Blog
Video
Caixin Weekly Sneak Peek
Topics
Asia New Vision Forum 2024
War in Ukraine
Evergrande Crisis
ESG & Carbon Goals
China-U.S. Rivalry
Coronavirus
Hobbled Huawei
Digital Currency
Fintech / Internet Finance
Selected
CX Daily
Weekly Must-Read
Energy Insider
Economic Indexes
Caixin Explains
Reg Watch
Subscriber Events
ThinkChina
The Wall Street Journal
News Graphics
Market Data
Company Index
Podcast
Highlights
Newsletter
Events
ESG
Promotion
中文
SUBSCRIBE
Clear
GO
Sort by:
Newest
Newest
Relevance
Oldest
Type:
All
All
News
CX Tech
Videos
Podcast
Gallery
In-Depth
Time:
Any Time
Any time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Range:
All
All
Headline
Byline
Full Text
Reset
Showing search results for
cui xiaotian
How AstraZeneca Bilked China’s Insurance Program Out of Millions of Yuan
China Loosens Grip on Contract Manufacturing of Biopharma Products
Latest Cover Story | Where is the Cure for Obesity?
Cover Story: China Formally Enlists ‘Miracle’ Drug in Fight Against Ballooning Obesity Rate
Cover Story: China Moves to Raise Retirement Age to Bolster Workforce, Ease Pension Pressure
China to Finalize Looser Controls on Human Genetic Material This Year
China Calls for Severe Punishments after Kidnapped Victims Murdered in Philippines
Caixin Explains: How China Is Overhauling Regulations on Genetic Resources
Cover Story: China Set to Ease Controls on Genetic Resources to Plug Biotech Innovation Gap
Caixin Explains: How Will the U.S. Import Tariff Hikes Impact Chinese Industries?
Load more
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通